Literature DB >> 26902049

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Ihsan Uslan, Serdar Olt, Ahmet T Eminler.   

Abstract

BACKGROUND/AIMS: Cirrhotic patients admitted to the hospital have a high mortality rate. The aim of this study was to evaluate predictors of mortality in patients hospitalized for specific complications of cirrhosis.
METHODOLOGY: All patients admitted to the gastroenterology service with cirrhosis during a 2-year period were retrospectively identified. We compared the clinical characteristics of patients who died and those who survived. Multivariable analysis was performed to determine predictors of mortality.
RESULTS: A total of 84 patients were included in the study. In hospital mortality rate was 35%. Hepatorenal syndrome development (41% vs 4%, p < 0.001), MELD score (17 vs 12, p = 0.003), Child Pugh score (11 vs 8, p < 0.001), serum creatinine (p < 0.001) and serum potassium values (p = 0.01) were significantly higher in patients who died. Stepwise logistic regression analysis revealed that the best model in prediction of death included serum potassium levels (OR = 2.182; 95% Cl: 1.189-4.006; p < 0.001) and Child Pugh score (OR = 2.140; 95% CI: 1.507-3,038; p = 0.012).
CONCLUSIONS: The mortality of cirrhotic patients admitted to hospital is significantly high. Prevention of acute kidney injury will be an appropriate approach for improving the survival in hospitalized patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26902049

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Serum potassium levels and prognosis in HBV-associated decompensated cirrhosis.

Authors:  JianJiang Huang; Ming Cai; Xia He
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

2.  Prediction model of emergency mortality risk in patients with acute upper gastrointestinal bleeding: a retrospective study.

Authors:  Lan Chen; Han Zheng; Saibin Wang
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.